GlassScriptPhysician profile
Brandon S Braddock
NPI 1336536697
$1,247.92
in general payments reported to CMS, 2019-2025
17 companies · $230 in 2025
The $230 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $204 · 2022: $456 · 2023: $278 · 2024: $79.56 · 2025: $230.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $588.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $587.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $162.33 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $139.07 | 2021-2023 | Ofev |
| Astrazeneca Pharmaceuticals LP | $123.59 | 2021-2023 | Breztri |
| Neurocrine Biosciences, INC. | $119.91 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $98.63 | 2022 | |
| Amgen INC. | $93.65 | 2022-2023 | Tezspire |
| Alnylam Pharmaceuticals INC. | $79.09 | 2023 | Amvuttra |
| Insmed, INC. | $69.62 | 2022-2023 | Arikayce |
| Inspire Medical Systems, INC. | $67.76 | 2024-2025 | Inspire |
| Philips North America LLC | $67.19 | 2022-2023 | |
| Actelion Pharmaceuticals US, INC. | $59.09 | 2022-2024 | Uptravi, Opsumit |
| Genzyme Corporation | $56.02 | 2022-2023 | |
| Vapotherm INC | $33.57 | 2021 | |
| Glaxosmithkline, LLC. | $28.13 | 2022-2024 | Nucala |
| Zoll Respicardia, INC. | $18.74 | 2025 | Remede System |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Csl Behring | $16.99 | 2023 | Kcentra |
| Pulmonx Corporation | $14.54 | 2025 | Chartis Catheter, Zephyr Endobronchial Valve, Pulmonx Chartis Tablet Console |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandon Braddock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.